Evidence map›Paper›PMID 39641584›Full record

ReviewAllergy2025

Endotyping in Chronic Rhinosinusitis-An EAACI Task Force Report.

Sanna Toppila-Salmi, Sietze Reitsma, Valérie Hox, Simon Gane, Ibon Eguiluz-Gracia, Mohamed Shamji, Juan Maza-Solano, Benjamin Jääskeläinen, Risto Väärä, Maria M Escribese and 5 more

Registry-linked trialAbstract readReview
In one paragraph

Review in Allergy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07616609 (A Randomized, Placebo-Controlled, Double-Blinded Trial of Preoperative Stapokibart With Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps), which is not on this map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07616609 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

A Randomized, Placebo-Controlled, Double-Blinded Trial of Preoperative Stapokibart With Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps

TypeinterventionalSponsorBeijing Tongren HospitalRan2026 to 2028Enrolled48ConditionsChronic Rhinosinusitis With Nasal Polyps (CRSwNP)ArmsStapokibart, Matched placebo
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Comparison of two classification systems for tissue eosinophilia in patients with chronic rhinosinusitis with nasal polyps.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  5. Article
  6. Artificial Intelligence in Rhinology: A State-of-the-Art Review of Clinical Readiness and Implementation Pathways.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sanna Toppila-SalmiDepartment of Otorhinolaryngology, University of Eastern Finland, Kuopio, Finland.ORCID 0000-0003-0890-6686
Sietze ReitsmaDepartment of Otorhinolaryngology/Head-Neck Surgery, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0003-1734-2632
Valérie HoxDepartment of Otorhinolaryngology, Head and Neck Surgery, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Simon GaneRoyal National Ear, Nose and Throat and Eastman Dental Hospital, University College London Hospitals NHS Trust, London, UK.
Ibon Eguiluz-GraciaAllergy Unit, Hospital Regional Universitario de Malaga. IBIMA-Plataforma BIONAND. RICORS Enfermedades Inflamatorias, Malaga, Spain.
Mohamed ShamjiNational Heart and Lung Institute, Imperial College London, London, UK.
Juan Maza-SolanoRhinology and Skull Base Unit, Department of Otolaryngology, University Hospital Virgen Macarena, Seville, Spain.
Benjamin JääskeläinenDepartment of Otorhinolaryngology, University of Eastern Finland, Kuopio, Finland.
Risto VääräDepartment of Otorhinolaryngology, University of Eastern Finland, Kuopio, Finland.
Maria M EscribeseInstitute of Applied Molecular Medicine Instituto de Medicina Molecular Aplicada Nemesio Díez (IMMA), Department of Basic Medical Sciences, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.ORCID 0000-0001-5057-5150
Adam ChakerDepartment of Otorhinolaryngology and Center for Allergy and Environment, Technische Universität München, München, Germany.
Aspasia KaraveliaDepartment of Otorhinolaryngology, General Hospital of Nafplio, Nafplio, Greece.
Michael RudenkoLondon Allergy and Immunology Centre, London, UK.
Philippe GevaertUpper Airways Research Laboratory, Department of Head and Skin, Ghent University, Ghent, Belgium.ORCID 0000-0002-1629-8468
Ludger KlimekCenter for Rhinology and Allergology, Wiesbaden, Germany.ORCID 0000-0002-2455-0192

Funding

European Academy of Allergy and Clinical Immunology
6 · The paper itself

Abstract

Chronic rhinosinusitis (CRS) is a clinical syndrome defined by typical sinonasal symptoms persisting for at least 12 weeks. CRS is divided into two distinct phenotypes, CRS with nasal polyps (CRSwNP) and without (CRSsNP). The aim of the review is to provide an update on the current knowledge in CRS endotypes. The prevailing hypothesis regarding the pathogenesis of CRS suggests that dysfunctional interactions between the host and environmental stressors at the mucosal surface drive the diverse inflammatory mechanisms. Genetic and epigenetic variations in the mucosal immune system are believed to play a significant role in the pathomechanisms of CRS. Various environmental agents (such as microbes and irritants) have been implicated in CRS. In a healthy state, the sinonasal mucosa acts as a barrier, modulating environmental stimulation and mounting appropriate immune responses against pathogens with minimal tissue damage. Different endotypes may exist based on the specific mechanistic pathways driving the chronic tissue inflammation of CRS. There is a need to understand endotypes in order to better predict, diagnose, and treat CRS. This literature review provides an update on the role of the endotypes in CRS and the limitations of endotyping CRS in clinical practice. Understanding of the pathogenesis and optimal management of CRS has progressed significantly in the last decades; however, there still are several unmet needs in endotype research.

Indexed as

RhinitisSinusitisAdvisory CommitteesChronic DiseaseHumansNasal PolypsPhenotypeRhinosinusitis

Identifiers

PMID39641584
PMCPMC11724251

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.